相关实验视频

Updated: May 12, 2026

Measurement of Spatial Stability in Precision Grip
09:36

Measurement of Spatial Stability in Precision Grip

Published on: June 4, 2020

肥胖患者的绝对和调整的手握强度值

Elena González Arnáiz1, Juan José López Gómez2, Diana Ariadel Cobo1

  • 1Servicio de Endocrinología y Nutrición, Complejo Asistencial Universitario de León, Gerencia de Salud de Castilla y León (SACYL), León, Spain; Departamento de Ciencias Biomédicas, Instituto de Biomedicina (IBIOMED), Universidad de León, León, Spain.

Endocrinologia, diabetes y nutricion
|May 16, 2025
PubMed
概括

与健康人群相比,肥胖个体表现出较低的手握力 (HGS),即使在调整身体成分后. 这突显了肥胖掩盖的潜在肌肉软弱,强调了在这个群体中需要量身定制的HGS评估.

关键词:
肥胖是什么意思 肥胖是什么意思肥胖症是一种脂肪.身体组成 身体组成身体构成 身体构成这是手臂的原则力量.手握的强度和握力的强度.这种肥胖症是sarcopénica.萨尔科佩尼亚是什么意思 萨尔科佩尼亚标本性肥胖症 标本性肥胖症

更多相关视频

Measuring the Motor Aspect of Cancer-Related Fatigue using a Handheld Dynamometer07:22

Measuring the Motor Aspect of Cancer-Related Fatigue using a Handheld Dynamometer

Published on: February 20, 2020

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults06:13

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults

Published on: December 1, 2023

相关概念视频

Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the patient.
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...